stimulant use disorder cocaine
Selected indexed studies
- Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. (Psychopharmacology (Berl), 2020) [PMID:32601988]
- Clinical management of psychostimulant withdrawal: review of the evidence. (Addiction, 2023) [PMID:36401591]
- β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon. (J Cardiovasc Pharmacol Ther, 2017) [PMID:28399647]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. (2020) pubmed
- The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. (2021) pubmed
- Clinical management of psychostimulant withdrawal: review of the evidence. (2023) pubmed
- β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon. (2017) pubmed
- Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use. (2022) pubmed
- Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence. (2023) pubmed
- Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern. (2025) pubmed
- Overamped: Stimulant Use and HIV Pathogenesis. (2023) pubmed
- Preclinical Profile of CM699 as a Medication Candidate for Stimulant Use Disorder. (2025) pubmed
- Inhibitory failures in cocaine use disorder: Not paying attention when there is a need to be cautious. (2021) pubmed